These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 3144165

  • 1. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV, Jackman WM, Akhtar M, Rinkenberger RL, Friday KJ, Dougherty AH, Tchou P, Yeung-Lai-Wah JA.
    Am J Cardiol; 1988 Dec 20; 62(19):31L-36L. PubMed ID: 3144165
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
    Miles WM, Chang MS, Heger JJ, Rinkenberger RL, Zipes DP, Prystowsky EN.
    Am Heart J; 1987 Jul 20; 114(1 Pt 1):26-33. PubMed ID: 3111237
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
    Chimienti M, Li Bergolis M, Moizi M, Salerno JA.
    J Am Coll Cardiol; 1989 Oct 20; 14(4):992-8. PubMed ID: 2507613
    [Abstract] [Full Text] [Related]

  • 4. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
    Akhtar M, Niazi I, Naccarelli GV, Tchou P, Rinkenberger R, Dougherty AH, Jazayeri M.
    Am J Cardiol; 1988 Dec 20; 62(19):45L-49L. PubMed ID: 3144167
    [Abstract] [Full Text] [Related]

  • 5. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M.
    J Am Coll Cardiol; 1989 Mar 15; 13(4):904-10. PubMed ID: 2494243
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct 15; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction.
    Derval N, Skanes AC, Gula LJ, Gray C, Denis A, Lim HS, Krahn AD, Yee R, Sacher F, Haïssaguerre M, Klein GJ.
    Heart Rhythm; 2013 Dec 15; 10(12):1785-91. PubMed ID: 24076446
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM, Lee JT, Woosley RL, Echt DS.
    Circulation; 1989 Nov 15; 80(5):1247-58. PubMed ID: 2805262
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]

  • 17. Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast atrioventricular nodal reentrant tachycardia: a prospective study.
    Efimova E, Riahi S, Fiedler L, Esato M, Sommer P, Richter S, Breithardt O, Rolf S, Bollmann A, Hindricks G, Arya A.
    Heart Rhythm; 2014 May 01; 11(5):871-6. PubMed ID: 24583097
    [Abstract] [Full Text] [Related]

  • 18. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V, Mewis C, Mayer F, Seipel L.
    Z Kardiol; 1990 Oct 01; 79(10):725-31. PubMed ID: 2087860
    [Abstract] [Full Text] [Related]

  • 19. The excitable gap in atrioventricular nodal reentrant tachycardia. Characterization with ventricular extrastimuli and pharmacologic intervention.
    Schuger CD, Steinman RT, Lehmann MH.
    Circulation; 1989 Aug 01; 80(2):324-34. PubMed ID: 2752559
    [Abstract] [Full Text] [Related]

  • 20. Unique electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia with different ventriculoatrial block patterns: effects of slow pathway ablation and insights into the location of the reentrant circuit.
    Otomo K, Okamura H, Noda T, Satomi K, Shimizu W, Suyama K, Kurita T, Aihara N, Kamakura S.
    Heart Rhythm; 2006 May 01; 3(5):544-54. PubMed ID: 16648059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.